IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. Its platform is a novel approach to cancer immunotherapy designed to activate naturally occurring T cells to target immunosuppressive mechanisms. The company was founded by Mai-Britt Zocca, Inge Marie Svane, and Mads Hald Andersen in December 2014 and is headquartered in Copenhagen, Denmark.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of IO Biotech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. IO Biotech Inc market cap is $405,791.00.
What is the 52-week high for IO Biotech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. IO Biotech Inc 52 week high is $2.79 as of May 05, 2026.
What is the 52-week low for IO Biotech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. IO Biotech Inc 52 week low is $0.003 as of May 05, 2026.
What is IO Biotech Inc stock price today?
IO Biotech Inc stock price today is $0.0056.
What was IO Biotech Inc stock price yesterday?
IO Biotech Inc stock price yesterday was $0.0056.
What is the Price-to-Book ratio of IO Biotech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. IO Biotech Inc P/B ratio is 0.4285.
What is the 50-day moving average of IO Biotech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. IO Biotech Inc 50-day moving average is $0.139.